KS

Kasirajan Selvi

Active Director Director DIN 02955328
DIN 02955328 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2010
Shareholding value •••• Premium profile

About Kasirajan Selvi

Data last updated:

Kasirajan Selvi is a Director at Hermes Animal Health Care Private Limited (since 2010). The company operates in Pharma. Hermes Animal Health Care Private Limited reported revenue of ₹1.12 Cr (FY 2024).

DIN 02955328
Primary Designation Director
Industry Pharma
First Appointment 26 Feb 2010
Oldest Company Age 16 yrs
Largest company Hermes Animal Health Care Private Limited · ₹1.12 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Feb 20102010₹1.12 Cr (FY 2024)Active

Board colleagues of Kasirajan Selvi

Directorship timeline

Open interactive timeline →
Hermes Animal Health Care Private Limited
Premium access

Shareholding and investment profile for Kasirajan Selvi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kasirajan Selvi

Kasirajan Selvi currently holds 1 directorship: Hermes Animal Health Care Private Limited (Director, since 26 Feb 2010, revenue ₹1.12 Cr (FY 2024)).

Kasirajan Selvi was first appointed on 26 Feb 2010 as Director at Hermes Animal Health Care Private Limited.

The current boards of Kasirajan Selvi's companies include Balasubramanian Navaneethakrishnan (Hermes Animal Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available